Large lymph node size harvested as prognostic factor in gastric cancer?

Revista Espanola de Enfermedades Digestivas

Volumn 102, Issue 3, 2010, Pages 169-175

  Espin F ^a   Bianchi, A ^a   Llorca, S ^a   Pulido, L ^a   Feliu, J ^a   de la Cruz, J ^a   Palomera, E ^b   Garcia O ^c   Remon, J ^d   Sunol X ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Epidemiology and Estatistics Department   (Spain)

^c Histology and Pathology Department   (Spain)

^d HOSPITAL DE MATARÓ   (Spain)

Author keywords

Gastric cancer; Lymphadenectomy; Postoperative survival; TNM staging

Indexed keywords

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SEX DIFFERENCE; STOMACH CANCER; GASTRECTOMY; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; STOMACH TUMOR; SURVIVAL;

AGED; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 77952762203     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082010000300003     Document Type: Article

References (16)

1. Cunningham D, Allum W, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson MY, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006; 355: 11-20.
2. Roukos DH. Innovative genomic-based model for personalized treatment of gastric cancer integrating current standards and new technologies. Expert Rev Mol Diag 2008; 8: 29-39.
3. Sano T. Tailoring treatment for curable gastric cancer. Br J Surg 2007; 94: 263-4.
4. Sobin LH, Wittekind CH. TNM Classification of malignant tumours. 5th ed. International Union Against Cancer. Heidelberg, Berlin, New York and Tokio: Springer-Verlag; 1997.
5. Gamon Giner R, Escrig Sos J, Salvador Sanchis JL, Ruiz del Castillo J, García Vila JH, Marcote Valdivieso E. Helical CT evaluation in the preoperative staging of gastric adenocarcinoma. Rev Esp Enferm Dig 2002; 94: 593-600.
6. Habermann CR, Weiss F, Riecken R, Honarpisheh H, Bohnacker S, Staedtler C, et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US. Radiology 2004; 230: 465-71.
7. Chung O, Oh ST, Kim BS, Yook JH, Kim SH, Im JT, et al. Large metastasic lymph node size, especially more than 2 cm. Independent predictor of poor prognosis in node positive gastric carcinoma. World J Surg 2008; 32: 262-6.
8. Dahr DK, Yoshimura H, Kinukawa N, Muruyama R, Tachibana M, Kohno H, et al. Metastasic lymph node size and colorectal cancer prognosis. J Am Coll Surg 2005; 200: 20-8.
9. Dahr DK, Kubota H, Maruyama R, Kyriazanosi D, Ohno S, Nagasue N. Prognostic significance of metastasic lymph node size in patients with gastric cancer. Br J Surg 2003; 90: 1522-30.
10. Liphman JC, De Meester TR. Preoperative diagnosis of lymph node metastasis: a dream. Gastric Cancer 2006; 9: 70-1.
11. Vieira Costa ML, Braga Ribeiro KC, Machado M, Vieira Costa AC, Montagnini AL. Prognostic store in gastric cancer: the importance of a combinant analysis of clinical, pathologic and therapeutic factors. Ann Surg Oncol 2006; 13: 843-50.
12. Espin F, Bianchi A, Pulido L, Feliu J, Moreno A, Fantova MJ. Rendimiento de la tomografía computerizada helicoidal en la predicción de afección ganglionar preoperatoria en cáncer gástrico. Med Clin 2009; 132: 214-6.
13. Chen CY, Hasu JS, Wu DC, Kang NY, Hsieh JS, Jaw TJ. Gastric cancer: preoperative local staging with a multidetector row CT. Correlation with surgical and histophatological results. Radiology 2007; 242: 472-82.
14. Butte JM, Torres J, Viviani P, Duarte I, Crovari F, Guzmán S, et al. Long term survival of patients operated for early gastric cancer. Rev Med Chi 2008; 136: 1424-30.
15. Onodera H, Tokunanga A, Yoshiyuki T, Kiyama T, Kato S, Matsukura N, et al. Surgical outcome of 483 patients with early gastric cancer: prognosis, postoperative morbidity and Mortality, and gastric remnant cancer. Hepathogastroenterology 2004; 51: 82-5.
16. Casado Martín F, Domínguez Díaz A, Rodríguez Sanjuán J, López Useros A, Cabrera García M, Moreno Muzás C, et al. Surgery of early gastric cancer: twenty five years experience. Hepathol Gastroenterol 2001; 24: 427-32.